Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HB | P07237 | 4/20 | 0.62 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.62 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.59 |
| ▸ | MAOA | P21397 | 3/20 | 0.56 |
| ▸ | XDH | P47989 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | SLCO2B1 | O94956 | 2/20 | 0.56 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.56 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA4 | P22748 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | NQO2 | P16083 | 1/20 | 0.54 |
| ▸ | HES1 | Q14469 | 2/20 | 0.52 |
| ▸ | FANCF | Q9NPI8 | 2/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | KDM1A | O60341 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20802114 | 0.93 | P4HB (0.66) | P4HBEPHX2MAOAXDHKDM4E | |
| SCHEMBL20802175 | 0.92 | EPHX2 (0.71) | P4HBSYNJ2EPHX2MAOAXDH | |
| SCHEMBL20802113 | 0.84 | GAA (0.69) | P4HBEPHX2MAOAXDHKDM4E | |
| SCHEMBL20802174 | 0.84 | KDM4E (0.64) | P4HBEPHX2MAOAXDHKDM4E | |
| SCHEMBL13927008 | 0.82 | P4HB (0.85) | P4HBSYNJ2EPHX2MAOAXDH | |
| SCHEMBL7085859 | 0.82 | P4HB (0.85) | P4HBSYNJ2EPHX2MAOAXDH | |
| Narcissin SCHEMBL7167500 | 0.77 | P4HB (1.00) | P4HBSYNJ2EPHX2MAOAXDH | |
| Narcissin SCHEMBL1305418 | 0.77 | P4HB (1.00) | P4HBSYNJ2EPHX2MAOAXDH | |
| Narcissin SCHEMBL15773535 | 0.77 | P4HB (1.00) | P4HBSYNJ2EPHX2MAOAXDH | |
| Narcissin SCHEMBL1305421 | 0.77 | P4HB (1.00) | P4HBSYNJ2EPHX2MAOAXDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10765128-B2 | Composition for prevention or treatment of metabolic syndrome or for antioxidation containing black bean leaf extracts and flavonol glysosides isolated therefrom as active ingredients | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2020-09-08 | — | — | US | disclosed |
| US-20190075823-A1 | COMPOSITION FOR PREVENTION OR TREATMENT OF METABOLIC SYNDROME OR FOR ANTIOXIDATION CONTAINING BLACK BEAN LEAF EXTRACTS AND FLAVONOL GLYSOSIDES ISOLATED THEREFROM AS ACTIVE INGREDIENTS | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2019-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10765128-B2 | Composition for prevention or treatment of metabolic syndrome or for antioxidation containing black bean leaf extracts and flavonol glysosides isolated therefrom as active ingredients | GPX1, GSTP1, GSS | P4HB 1549/4885SYNJ2 3861/4885EPHX2 3943/4885 |
| US-20190075823-A1 | COMPOSITION FOR PREVENTION OR TREATMENT OF METABOLIC SYNDROME OR FOR ANTIOXIDATION CONTAINING BLACK BEAN LEAF EXTRACTS AND FLAVONOL GLYSOSIDES ISOLATED THEREFROM AS ACTIVE INGREDIENTS | GPX1, GSTP1, PON1 | P4HB 1470/4885SYNJ2 3778/4885EPHX2 2927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.